| III-35 Wonkyung Byon Apixaban for treatment of venous thromboembolism (VTEtx): Use of Model-Based Meta-Analysis (MBMA) to support Phase 3 dose selection and beyond Thursday 09:55-11:30 |
| III-35 Wonkyung Byon Apixaban for treatment of venous thromboembolism (VTEtx): Use of Model-Based Meta-Analysis (MBMA) to support Phase 3 dose selection and beyond Thursday 09:55-11:30 |